Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{65044805f8204d7d9d0edb5be9e673d2,

title = "Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma",

author = "Gunther, \{Jillian R.\} and Pinnix, \{Chelsea C.\}",

year = "2024",

month = jul,

doi = "10.1016/S2352-3026(24)00177-7",

language = "English (US)",

volume = "11",

pages = "e472--e473",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Elsevier Limited",

number = "7",

}

TY - JOUR

T1 - Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma

AU - Gunther, Jillian R.

AU - Pinnix, Chelsea C.

PY - 2024/7

Y1 - 2024/7

UR - https://www.scopus.com/pages/publications/85196657062

UR - https://www.scopus.com/pages/publications/85196657062#tab=citedBy

U2 - 10.1016/S2352-3026(24)00177-7

DO - 10.1016/S2352-3026(24)00177-7

M3 - Comment/debate

C2 - 38937019

AN - SCOPUS:85196657062

SN - 2352-3026

VL - 11

SP - e472-e473

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 7

ER -